NCT02363127View on ClinicalTrials.gov

Subcutaneous Progesterone Versus Vaginal Progesterone for Endometrial Preparation in Fresh Donated Oocytes Recipients

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions

Infertility

Interventions

DRUG

subcutaneous progesterone

subcutaneous progesterone 25 mg/day

DRUG

vaginal progesterone

vaginal progesterone in capsules 200 mg/3 times a day

Trial Locations (1)

03016

Instituto Bernabeu, Alicante

Sponsors

Lead Sponsor

Instituto Bernabeu

All Listed Sponsors

lead

Instituto Bernabeu

OTHER